-
-
-
-
-
-
-
Urovant Sciences Enters Into Definitive Agreement for Sumitovant Biopharma to Acquire All Outstanding Shares
-
-
-
-
-
-
-
Urovant Sciences (UROV) Misses Q4 EPS by 44c
-
-
-
-
-
-
-
Urovant Sciences Reports 2019 Second Fiscal Quarter Financial Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 03/19: (STNE) (CRBP) (HF) Higher; (AQB) (UROV) (DSW) Lower (more...)
-
-
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

